November 22, 2024

A Small Mutation Can Make Zika Virus Even More Dangerous – And Potentially Breakthrough Pre-Existing Immunity

Microcephaly is an abnormality where an infants head is smaller than anticipated in contrast to other infants of the same sex and age. Children with microcephaly often have smaller sized brains that may not have established effectively.

How Zika break outs could happen, even in areas with prior immunity.
Scientists at La Jolla Institute for Immunology (LJI) have actually found that the Zika infection can mutate to end up being more contagious– and potentially development pre-existing immunity.
” The world should keep an eye on the development of this Zika infection variant,” states LJI Professor Sujan Shresta, Ph.D., who co-led the Cell Reports study with Professor Pei-Yong Shi, Ph.D., of the University of Texas Medical Branch (UTMB).

Zika infection and dengue infection overlap in many countries worldwide. Like Zika, the dengue infection is a mosquito-borne flavivirus, and thus shares lots of biological properties. The viruses are comparable enough that the immune reaction stimulated by prior dengue exposure can offer protection against Zika.
“Dengue and Zika are RNA viruses, which suggests they can alter their genome,” describes Shresta. The researchers discovered it is fairly simple for Zika infection to get a single amino acid modification that allows the virus to make more copies of itself– and help infections take hold more easily.

Zika virus is spread out by mosquitoes, and the symptoms of Zika infection in adults are typically moderate. The virus can contaminate an establishing fetus, resulting in major birth problems such as microcephaly.
Zika virus and dengue infection overlap in many nations worldwide. Like Zika, the dengue virus is a mosquito-borne flavivirus, and thus shares many biological properties. In reality, the infections are similar enough that the immune reaction triggered by previous dengue exposure can provide defense against Zika.
” In locations where Zika prevails, a large majority of individuals have already been exposed to dengue virus and have both T cells and antibodies that cross-react,” states Shresta.
Both viruses are also fast to alter. “Dengue and Zika are RNA infections, which means they can alter their genome,” describes Shresta. “When there are a lot of mosquitoes and so numerous human hosts, these viruses are continuously returning and forth and progressing.”
Repeatedly changing back and forth between mosquito cells and mice supplied researchers with a window into how Zika infection naturally evolves as it experiences more hosts. Credit: La Jolla Institute for Immunology Credit: La Jolla Institute for Immunology.
To study Zikas busy evolution, the LJI group recreated infection cycles that repeatedly changed back and forth in between mosquito cells and mice. This work gave the LJI researchers a window into how Zika virus naturally evolves as it experiences more hosts.
The scientists found it is relatively simple for Zika infection to get a single amino acid modification that enables the virus to make more copies of itself– and assist infections take hold more easily. This anomaly (called NS2B I39V/I39T anomaly) improves the viruss ability to reproduce in both mice and mosquitoes. This Zika version also revealed increased replication in human cells.
” This single anomaly suffices to improve Zika infection virulence,” states study first author Jose Angel Regla-Nava, Ph.D., former postdoctoral scientist at LJI and current Associate Professor at the University of Guadalajara, Mexico. “A high replication rate in either a mosquito or human host might increase viral transmission or pathogenicity– and cause a new break out.”
Includes Shresta, “The Zika version that we determined had developed to the point where the cross-protective resistance managed by prior dengue infection was no longer efficient in mice. For us, if this variant ends up being widespread, we might have the same issues in genuine life.”
So how can we prepare for this kind of variation? Shrestas laboratory is already looking at ways to tailor Zika vaccines and treatments that combat this hazardous anomaly. She will also continue to work closely with Regla-Nava to much better understand exactly how this mutation assists Zika reproduce more effectively.
” We desire to understand at what point in the viral life process this anomaly makes a difference,” states Shresta.
Reference: “A Zika infection anomaly boosts transmission capacity and provides escape from protective dengue virus immunity” by Jose Angel Regla-Nava, Ying-Ting Wang, Camila R. Fontes-Garfias, Yang Liu, Thasneem Syed, Mercylia Susantono, Andrew Gonzalez, Karla M. Viramontes, Shailendra Kumar Verma, Kenneth Kim, Sara Landeras-Bueno, Chun-Teng Huang, Daniil M. Prigozhin, Joseph G. Gleeson, Alexey V. Terskikh, Pei-Yong Shi and Sujan Shresta, 12 April 2022, Cell Reports.DOI: 10.1016/ j.celrep.2022.110655.
Extra authors of the research study, “A Zika Virus Mutation Enhances Transmission Potential and Confers Escape from Protective Dengue Virus Immunity,” include very first author Jose Angel Regla-Nava, Ying-Ting Wang, Camila R Fontes-Garfias, Yang Liu, Thasneem Syed, Mercylia Susantono, Andrew Gonzalez, Karla Viramontes, Shailendra Verma, Kenneth Kim, Sara Landeras-Bueno, Chun-Teng Huang, Daniil M Prigozhin, Joseph G Gleeson, and Alexey V Terskikh.
This research was supported by the National Institutes of Health (R01 AI153500, R01 AI163188, R56 AI148635, U01 AI151810, R01 NS106387, R01 AI134907, R43 AI145617, and UL1 TR001439), the Sealy & & Smith Foundation, the Kleberg Foundation, the John S. Dunn Foundation, the Amon G. Carter Foundation, the Gilson Longenbaugh Foundation, and the Summerfield Robert Foundation.